Jonathan Richard Rice - Dec 4, 2024 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)

Role
Chief Operating Officer
Signature
Jon Rice, COO
Stock symbol
KBLB
Transactions as of
Dec 4, 2024
Transactions value $
$0
Form type
4
Date filed
3/24/2025, 04:30 PM
Previous filing
Feb 17, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KBLB Class A Common Stock Option Exercise of in-the-money or at-the-money derivative security +1.11M +34.66% 4.32M Dec 4, 2024 Class A Common Stock 1.1M $0.09 Direct F1
transaction KBLB Class A Common Stock Options Exercise of in-the-money or at-the-money derivative security +182K +4.2% 4.5M Jan 15, 2025 Class A Common Stock 180K $0.94 Direct F1
transaction KBLB Class A Common Stock Options Exercise of in-the-money or at-the-money derivative security +888K +19.78% 5.38M Jan 15, 2025 Class A Common Stock 879K $0.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person exercised the derivative security through a cashless exercise of stock options.